SMAD4 and neoplasm: Increased expression of SMAD4 in nucleus and cytoplasm, the tumor epithelial compartment, and cytoplasm in the stromal compartment; RUNX3 in the nucleus or cytoplasm in both the tumor epithelial and stromal compartments; and IRS-1 in the stromal cytoplasm were all significant predictors of a favorable DSS.